全文获取类型
收费全文 | 31143篇 |
免费 | 3055篇 |
国内免费 | 9篇 |
出版年
2022年 | 190篇 |
2021年 | 404篇 |
2020年 | 291篇 |
2019年 | 354篇 |
2018年 | 495篇 |
2017年 | 438篇 |
2016年 | 803篇 |
2015年 | 1272篇 |
2014年 | 1417篇 |
2013年 | 1681篇 |
2012年 | 2240篇 |
2011年 | 2229篇 |
2010年 | 1515篇 |
2009年 | 1297篇 |
2008年 | 1780篇 |
2007年 | 1823篇 |
2006年 | 1606篇 |
2005年 | 1546篇 |
2004年 | 1628篇 |
2003年 | 1438篇 |
2002年 | 1372篇 |
2001年 | 487篇 |
2000年 | 410篇 |
1999年 | 463篇 |
1998年 | 408篇 |
1997年 | 306篇 |
1996年 | 282篇 |
1995年 | 264篇 |
1994年 | 283篇 |
1993年 | 261篇 |
1992年 | 320篇 |
1991年 | 288篇 |
1990年 | 287篇 |
1989年 | 284篇 |
1988年 | 276篇 |
1987年 | 247篇 |
1986年 | 245篇 |
1985年 | 232篇 |
1984年 | 244篇 |
1983年 | 188篇 |
1982年 | 215篇 |
1981年 | 214篇 |
1980年 | 186篇 |
1979年 | 161篇 |
1978年 | 172篇 |
1977年 | 131篇 |
1976年 | 149篇 |
1975年 | 142篇 |
1974年 | 150篇 |
1973年 | 126篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
2.
The effect of carbohydrate depletion on procoagulant activity and in vivo survival of highly purified human factor VIII 总被引:1,自引:0,他引:1
P J Fay S I Chavin J E Malone D Schroeder F E Young V J Marder 《Biochimica et biophysica acta》1984,800(2):152-158
Human factor VIII procoagulant protein (factor VIII) was purified using a modification of our previously described method, in which Sephacryl S-400 elution, rather than QAE-cellulose chromatography, served as the final purification step. The protein had a specific activity of more than 2500 U/mg and consisted of a single polypeptide (Mr 100 000) when analyzed by SDS-polyacrylamide gel electrophoresis. Factor VIII was shown to be a glycoprotein by staining with periodic acid-Schiff's reagent following electrophoresis. Treatment of factor VIII with a mixture of exo- and endoglycosidases caused a reduction by about 50% in the intensity of periodic acid-Schiff staining, as determined by scanning densitometry, and an increase in electrophoretic mobility (equivalent to a new Mr 95 000). Removal of this portion of the total carbohydrate had no significant effect on factor VIII clotting activity or on thrombin potentiation of clotting activity. The in vivo survival curves of a native and sugar-depleted 125I-labeled factor VIII both showed similar patterns of initial rapid decay to 60 and 40% activity, respectively, followed by a one-half decay time of 4 h for both. These results suggest that the carbohydrate portion of human factor VIII does not contribute significantly to either clotting function in vitro or to biological turnover in vivo. 相似文献
3.
Cristian A. Acevedo Elizabeth Y. Sanchez Juan G. Reyes Manuel E. Young 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》2010,878(3-4):449-455
It is known that skin releases volatile organic compounds to the environment, and also that its emission pattern changes with aging of the skin. It could be considered, that these compounds are intermediaries in cell metabolism, since many intermediaries of metabolic pathways have a volatile potential. In this work, a simple and non-destructive method consisting of SPME sampling and GC/MS analysis was developed to identify volatile organic emanations from cell cultures. This technique, applied to skin cells culture, indicates that the cells or cell metabolism produce several skin emissions. Chemometric analysis was performed in order to explore the relationship between a volatile profile and the senescence of cell cultures. Volatile profiles were different for cell cultures in different degrees of senescence, indicating that volatile compound patterns could be used to provide information about the age of skin cells. 相似文献
4.
5.
6.
7.
8.
9.
Shira Weingarten-Gabbay Susan Klaeger Siranush Sarkizova Leah R. Pearlman Da-Yuan Chen Kathleen M.E. Gallagher Matthew R. Bauer Hannah B. Taylor W. Augustine Dunn Christina Tarr John Sidney Suzanna Rachimi Hasahn L. Conway Katelin Katsis Yuntong Wang Del Leistritz-Edwards Melissa R. Durkin Christopher H. Tomkins-Tinch Pardis C. Sabeti 《Cell》2021,184(15):3962-3980.e17
- Download : Download high-res image (225KB)
- Download : Download full-size image
10.
Bruce R. Dorrbecker Susan H. Mercik Paul A. Kramer 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》1984,336(1)
A high-performance liquid chromatographic procedure is reported for reproducibly and sensitively quantitating caffeine and its N-demethylated metabolite paraxanthine in micro-samples. A 5-μm reversed-phase radial compression column and 214-nm fixed wavelength ultraviolet detector were used to attain a sensitivity sufficient to quantitate these compounds at concentratios as low as 80 ng/ml using only 25 μl of sample. The assay is applicable to microliter samples of whole blood, serum, plasma, saliva, amniotic, cerebro-spinal and gastric fluids such as might be obtained in studies involving small animals or neonates. The utility of the assay is illustrated with caffeine and paraxanthine levels measured in several maternal and fetal fluids following constant-rate intravenous infusion of caffeine into a rabbit throughout pregnancy. 相似文献